AI-Powered Health Revolution: Ketryx and DeepHealth Accelerate Innovation
Generado por agente de IAEli Grant
miércoles, 4 de diciembre de 2024, 1:42 pm ET1 min de lectura
KEX--
The intersection of artificial intelligence (AI) and healthcare is poised to revolutionize the way we diagnose, treat, and manage diseases. Ketryx, a pioneering AI-enabled connected application lifecycle management platform, has recently announced a strategic partnership with DeepHealth, a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT). This collaboration aims to accelerate the delivery of innovative AI-powered health informatics solutions, transforming radiology workflows and enhancing patient care.
DeepHealth's cloud-native operating system, along with Ketryx's connected lifecycle management software, drives operational efficiency, improves clinical confidence, and ensures better care delivery. According to the FDA, radiology leads the way in AI/ML adoption within the Software as a Medical Device (SaMD) sector, with 79% of newly approved devices leveraging these technologies to enhance diagnostics and patient care.

By integrating Ketryx's software, DeepHealth can accelerate product development while maintaining quality and compliance. The platform's microservice architecture allows for easy integration of AI advancements, enabling DeepHealth to accelerate development cycles and stay at the forefront of AI-driven radiology. Moreover, Ketryx's automation of documentation and end-to-end traceability across preferred developer tools like Jira and GitLab ensures regulatory compliance and expedites product releases.
The partnership between Ketryx and DeepHealth is a testament to the growing importance of AI in healthcare. As radiology's role in healthcare expands, a transformative shift in informatics is essential to keep pace with increasing economic pressure, staff shortages, and evolving patient needs. By harnessing the power of AI and streamlining workflows, DeepHealth and Ketryx are paving the way for a more efficient, accurate, and patient-centric healthcare system.
In conclusion, the collaboration between Ketryx and DeepHealth signifies a significant step towards revolutionizing radiology workflows and enhancing patient care. By leveraging AI and modernizing development processes, these innovative companies are setting the stage for a more technologically advanced and efficient healthcare landscape. Investors should take note of this transformative trend, as the intersection of AI and healthcare presents numerous opportunities for growth and innovation.
RDNT--
The intersection of artificial intelligence (AI) and healthcare is poised to revolutionize the way we diagnose, treat, and manage diseases. Ketryx, a pioneering AI-enabled connected application lifecycle management platform, has recently announced a strategic partnership with DeepHealth, a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT). This collaboration aims to accelerate the delivery of innovative AI-powered health informatics solutions, transforming radiology workflows and enhancing patient care.
DeepHealth's cloud-native operating system, along with Ketryx's connected lifecycle management software, drives operational efficiency, improves clinical confidence, and ensures better care delivery. According to the FDA, radiology leads the way in AI/ML adoption within the Software as a Medical Device (SaMD) sector, with 79% of newly approved devices leveraging these technologies to enhance diagnostics and patient care.

By integrating Ketryx's software, DeepHealth can accelerate product development while maintaining quality and compliance. The platform's microservice architecture allows for easy integration of AI advancements, enabling DeepHealth to accelerate development cycles and stay at the forefront of AI-driven radiology. Moreover, Ketryx's automation of documentation and end-to-end traceability across preferred developer tools like Jira and GitLab ensures regulatory compliance and expedites product releases.
The partnership between Ketryx and DeepHealth is a testament to the growing importance of AI in healthcare. As radiology's role in healthcare expands, a transformative shift in informatics is essential to keep pace with increasing economic pressure, staff shortages, and evolving patient needs. By harnessing the power of AI and streamlining workflows, DeepHealth and Ketryx are paving the way for a more efficient, accurate, and patient-centric healthcare system.
In conclusion, the collaboration between Ketryx and DeepHealth signifies a significant step towards revolutionizing radiology workflows and enhancing patient care. By leveraging AI and modernizing development processes, these innovative companies are setting the stage for a more technologically advanced and efficient healthcare landscape. Investors should take note of this transformative trend, as the intersection of AI and healthcare presents numerous opportunities for growth and innovation.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios